#CNS CORERO NETWORK +5%; Q1 26 started strongly, which has significantly exceeded Q1 25. Confident outlook.
52
We explore 5 trends that will shape the central nervous system (CNS) market for biopharma therapies in 2026.
From bluematterconsulting.com









